The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
reported to
the Securities and Exchange Commission (SEC)
by insider Mckenzie Paul since year 2005.
The trader's CIK number is 1677903.
At the time of this reporting, Mckenzie Paul is the EVP Pharmaceutical Oper & Tech of Biogen Inc. .
(stock ticker symbol BIIB).
See this page for all insider trading activities at Biogen Inc. .
| Trade Date | Symbol | Company Name (Issuer) | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|---|
| 2018-03-01 | BIIB | Biogen Inc. | Option Ex | 532 | .00 | 0 |
| 2018-02-15 | BIIB | Biogen Inc. | Option Ex | 1,472 | .00 | 0 |
| 2017-03-01 | BIIB | Biogen Inc. | Option Ex | 481 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Mckenzie Paul (EVP Pharmaceutical Oper & Tech of Biogen Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.